October 6, 2017
EAVI2020’s partner institutions presented the latest research on HIV vaccines at the 9th IAS Conference on HIV Science. The Conference The IAS Conference on HIV Science is the largest open scientific conference on..
The eAccess Meetings project In 2016, The Global HIV Vaccine Enterprise and Keystone Symposia inaugurated a collaboration to produce an ePanel discussion and series of SciTalks presentations that brought together k..
The June 2017 EAVI2020 Newsletter is here! This new edition features our Third PhD course on HIV immunology and vaccines, which took place on 23-26 April 2017 in Stockholm. Find out about the exciting topics that ..
On 23-26 April 2017, EAVI2020 celebrated its Third PhD course on HIV immunology and vaccines. The course was organised by project partners Karolinska Institutet and Fundació Clinic per a la Recerca Biomèdica and to..
EAVI2020’s partner institutions presented the latest research on HIV vaccines at the Keystone Symposia on HIV vaccines. As part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gate..
The Beijerinck Premium is intended to encourage virology research and is awarded every two years. Marit van Gils is a post-doc researcher at Academisch Medisch Centrum and is part of the team working in EAVI2020. This..
We are excited to present the fifth issue of the EAVI2020 Newsletter! In this issue you will find out about: EAVI2020's published papers on year 1 Links to talks by EAVI2020 at the 2016 Keystone Symposia on H..
The Global HIV Vaccine Enterprise in collaboration with Keystone Symposia organized an ePanel discussion and series of SciTalks presentations that brought together key experts in the HIV prevention vaccine field. The ..
Prof Robin Shattock (Imperial) presented at the plenary session of the Spanish AIDS society (GESIDA)' s AIDS Research Network (RIS) annual meeting in San Sebastian, Spain, 30th November 2016. Prof Shattock was also i..
Fundació Clínic per a la Recerca Biomèdica and Karolinska Institutet organised the Second course on HIV immunology and vaccines in Barcelona, 9th November 2016. Twenty four students from all over Europe joined th..
17-21 November 2016 Dr Joan Joseph from Fundació Clínic per a la Recerca Biomèdica presented lessons learned on "Pre-clinical development of recombinant BCG based HIV vaccine" at the event, which took place at th..
Coinciding with the project’s one year anniversary, we are excited to publish the fourth issue of the EAVI2020 Newsletter! In this issue we have covered our upcoming EAVI2020 first annual meeting and 2nd PhD course..
The Center for Immunology and Microbial Infection (CIMI-Paris) is a research unit of Inserm - Institut National de Santé et de Recherche Médicale (French National Institutes of Health). At CIMI-Paris and within the ..
EAVI2020’s partner institutions will be at the HIVR4P Conference in Chicago this week. HIV Research for Prevention 2016: AIDS Vaccine, Microbicide, and ARV-based Prevention Science (HIVR4P 2016) will be held 17–21..
Marit van Gils, who is part of the Academisch Medisch Centrum's team involved in EAVI2020, has been selected as one of eight New Investigator Award recipients of the HIV Research for Prevention 2016: AIDS Vaccine, Microb..
Prof José (Pepe) Alcami is the director of the AIDS Immunopathogenesis Unit at Instituto de Salud Carlos III and Coordinator of the Spanish AIDS Research Network (RIS). The AIDS Immunopathogenesis Unit The AIDS Im..
Prof Quentin Sattentau’s lab is one of the groups at the University of Oxford working on the EAVI2020 project. Their work focuses on the function of HIV-1 Env and HIV-1 neutralizing antibodies. Background on the fun..
The 8th edition of the ICAR (Italian Conference on AIDS and Antiviral Research) will be held in Milan, at University of Milano-Bicocca, from June 6-8, 2016. EAVI2020 partner Ospedale San Raffaele (OSR) will present a ..
The May issue of the EAVI2020 Newsletter has been published! In this issue we have covered the most recent project events and news. You can also find links to international press articles about EAVI2020 and a list ..
As part of the EAVI2020 Continuing Education and Training in an HIV vaccine development Programme, project partners Fundació Clinic per a la Recerca Biomèdica and Karolinska Institutet have organized the first training..
The first EAVI2020 Newsletter was recently launched! This issue of the project's Newsletter features three short articles on the first activities of the project since its kick-off date on 1st November 2015. It..
The Neutralizing Antibody Consortium (NAC) held its Annual meeting in La Jolla, California, on the 16th to 18th February 2016. The NAC was launched by EAVI2020’s project partner IAVI in 2002 to solve a fundamental p..
Imperial College hosted EAVI2020 's kick-off meeting in London on Thursday 26th November 2015. Representatives from the project’s partner institutions travelled to London to attend the kick-off meeting of this excit..
In response to circa 2 billion euros of Health and ICT innovation-based funding about to be launched by the European Commission, Vision 2020: The Horizon Network hosted London's Horizon 2020 Health-Tech event on 29 and 3..
A new 23 million euro initiative to accelerate the search for an effective HIV vaccine begins today. Financed by the European Commission, the European AIDS Vaccine Initiative (EAVI2020) brings together leading HIV res..